Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Schiffenbauer

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Rheumatology|September 13, 2014
Imaging: seeing muscle in new waysAdam Schiffenbauer
Journal of Virology|March 31, 2006
Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural proteinBrian D Poole, Jing Zhou, Amy Grote, et al.
Arthritis and Rheumatism|September 30, 2008
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathiesTerrance P O'Hanlon, Lisa G Rider, Adam Schiffenbauer, et al.
Plos One|March 23, 2026
Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositisMeghan Corrigan Nelson, Lisa G Rider, Hanna Kim, et al.
Clinical Rheumatology|January 22, 2020
Rheumatology capacity building: implementing a rheumatology curriculum for Liberian health-care providers in 2016Laura B Lewandowski, Adam Schiffenbauer, JoAnn M Mican, et al.
Rheumatology (Oxford, England)|September 25, 2025
PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathiesEmma M Austenfeld, Sara E Sabbagh, Melodee Liegl, et al.
Autoimmunity Reviews|April 3, 2020
Calcinosis Biomarkers in Adult and Juvenile DermatomyositisMelody P Chung, Carrie Richardson, David Kirakossian, et al.
Rheumatology (Oxford, England)|November 29, 2025
Factors associated with interstitial lung disease among patients with idiopathic inflammatory myopathiesJesse C Wilkerson, Frederick W Miller, Matthew F Bridge, et al.
Seminars in Arthritis and Rheumatism|November 28, 2017
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Megha Garg, Christine Castro, et al.
Clinical and Experimental Rheumatology|June 25, 2025
Infections preceding diagnosis associated with myositis phenotypes in a national patient registryTakuma Ohnishi, Jesse Wilkerson, Nastaran Bayat, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Rheumatology|September 13, 2014
Imaging: seeing muscle in new waysAdam Schiffenbauer
Journal of Virology|March 31, 2006
Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural proteinBrian D Poole, Jing Zhou, Amy Grote, et al.
Arthritis and Rheumatism|September 30, 2008
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathiesTerrance P O'Hanlon, Lisa G Rider, Adam Schiffenbauer, et al.
Plos One|March 23, 2026
Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositisMeghan Corrigan Nelson, Lisa G Rider, Hanna Kim, et al.
Clinical Rheumatology|January 22, 2020
Rheumatology capacity building: implementing a rheumatology curriculum for Liberian health-care providers in 2016Laura B Lewandowski, Adam Schiffenbauer, JoAnn M Mican, et al.
Rheumatology (Oxford, England)|September 25, 2025
PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathiesEmma M Austenfeld, Sara E Sabbagh, Melodee Liegl, et al.
Autoimmunity Reviews|April 3, 2020
Calcinosis Biomarkers in Adult and Juvenile DermatomyositisMelody P Chung, Carrie Richardson, David Kirakossian, et al.
Rheumatology (Oxford, England)|November 29, 2025
Factors associated with interstitial lung disease among patients with idiopathic inflammatory myopathiesJesse C Wilkerson, Frederick W Miller, Matthew F Bridge, et al.
Seminars in Arthritis and Rheumatism|November 28, 2017
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Megha Garg, Christine Castro, et al.
Clinical and Experimental Rheumatology|June 25, 2025
Infections preceding diagnosis associated with myositis phenotypes in a national patient registryTakuma Ohnishi, Jesse Wilkerson, Nastaran Bayat, et al.
Pageof 3